Sign In
Buy CYDY
$0.276
-0.0143 (-4.93%)
At Close: Jun 03, 2026
CytoDyn files new protocol with FDA for four doses of leronlimab for critically ill coronavirus patients
08:25am, Thursday, 01'st Apr 2021
CytoDyn Inc (OTCQB:CYDY), a biotechnology company developing its flagship drug Vyrologix (leronlimab-PRO 140) for multiple indications, revealed Thursday that after several weeks of discussions with t
Philadelphia, Pennsylvania--(Newsfile Corp. - April 1, 2021) - Berger Montague is investigating potential securities fraud claims against CytoDyn, Inc. ("CytoDyn" or the "Company") on behalf of invest
CytoDyn to Hold Webcast on April 6 to Provide a Full Update on Its Activities
06:15am, Thursday, 01'st Apr 2021
VANCOUVER, Washington, April 01, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 14
Trial commencement will be expedited by enrolling patients in Brazil, U.K., and Canada while immediate EUA requests are pursued in multiple countries
New York, New York--(Newsfile Corp. - March 31, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of C
New York, New York--(Newsfile Corp. - March 31, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTCQB: CYDY) alleging that
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for CytoDyn Inc. Investors in Securities Fraud Class Action Lawsuit
07:37pm, Tuesday, 30'th Mar 2021
RADNOR, Pa., March 30, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of CytoDyn Inc. (OTCMKTS: CYDY) ("CytoDyn") that a securities fraud class action lawsu
CytoDyn's leronlimab decreases mortality by 82% among critically ill coronavirus patients after two weeks in CD12 trial
09:09am, Tuesday, 30'th Mar 2021
CytoDyn Inc (OTCQB:CYDY) announced additional results Tuesday from its CD12 trial of Vyrologix (leronlimab-PRO 140) in severe-to-critical coronavirus (COVID-19), revealing that the drug decreases mort
Clinical outcome improvement (based on ordinal scale) with leronlimab at day 14 was 400% better than placebo arm with p-value of 0.021
Radnor, Pennsylvania--(Newsfile Corp. - March 29, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn") that a securities class action
CD12 trial results also indicated that five out of six patients on ECMO recovered
The Philippines FDA Approves the Use of Leronlimab to Treat a COVID-19 Patient
06:00am, Monday, 29'th Mar 2021
CytoDyn is simultaneously pursuing EUA in the Philippines while expanding its access under CSP
Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds CYDY Investors for Securities Fraud Class Action Lawsuit
01:42pm, Friday, 26'th Mar 2021
Radnor, Pennsylvania--(Newsfile Corp. - March 26, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed in the United
New York, New York--(Newsfile Corp. - March 26, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytoDyn Inc. (OTCQB: CYDY) alleging that
New Orleans, Louisiana--(Newsfile Corp. - March 25, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have
